Latest Breaking News On - பில் மணல் - Page 1 : comparemela.com

Medolife Rx Breaks Ground on Lab Facility and Increases Scorpion Count at First-of-Its-Kind Reservation in the Dominican Republic

Medolife Rx Breaks Ground on Lab Facility and Increases Scorpion Count at First-of-Its-Kind Reservation in the Dominican Republic
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDominican republicPhil sandsArthur mikaelianKyle porterExchange commissionMedolife rx incMinistry of environmentDrug administrationAquanta incInvestigational new drugHarbor statementSecurities litigation reform actஒன்றுபட்டது மாநிலங்களில்டொமினிகன் குடியரசுபில் மணல்

Medolife Rx s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic

Medolife Rx s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDominican republicPhil sandsArthur mikaelianKyle porterExchange commissionMedolife rx incNewmediawire medolife rx incDrug administrationAquanta incUnited states foodInvestigational new drugHarbor statementSecurities litigation reform actஒன்றுபட்டது மாநிலங்களில்டொமினிகன் குடியரசு

Medolife Rx s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic

United statesDominican republicPhil sandsArthur mikaelianKyle porterExchange commissionMedolife rx incNewmediawire medolife rx incDrug administrationAquanta incWall streetUnited states foodInvestigational new drugHarbor statementSecurities litigation reform actஒன்றுபட்டது மாநிலங்களில்

Medolife Rxs Lead Drug Candidate Escozine Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

United statesDominican republicPhil sandsArthur mikaelianKyle porterExchange commissionMedolife rx incDrug administrationAquanta incUnited states foodInvestigational new drugHarbor statementSecurities litigation reform actProducts and servicesDrug approvalsCoronavirus pandemic

Medolife Rx s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic Other OTC:QNTA

Medolife Rx’s Lead Drug Candidate Escozine® Recommended by Doctor for Use in Cancer Treatment Regimen in Dominican Republic April 01, 2021 09:00 ET | Source: Quanta, Inc. Quanta, Inc. BURBANK, Calif., April 01, 2021 (GLOBE NEWSWIRE) via NewMediaWire Medolife Rx, Inc. ( Medolife ), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that Dr. Ramón Feliz MD, PhD, an oncological surgeon practicing medicine in the Dominican Republic, has made an official recommendation for inclusion of Medolife’s drug candidate Escozine® in treatment regimens for patients with various forms of cancer including pancreatic, breast, prostate, and different segments of colon cancer.

United statesDominican republicPhil sandsArthur mikaelianKyle porterExchange commissionMedolife rx incNewmediawire medolife rx incDrug administrationAquanta incUnited states foodInvestigational new drugHarbor statementSecurities litigation reform actOther otc qntaஒன்றுபட்டது மாநிலங்களில்